Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hon.3016

PubMed Identifier: 35544413

Publication URI: http://europepmc.org/abstract/MED/35544413

Type: Journal Article/Review

Volume: 40

Parent Publication: Hematological oncology

Issue: 3

ISSN: 0278-0232